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Water envelope has a critical impact on the
design of protein–protein interaction inhibitors†
Ekaterina L. Ratkova, *ab Maciej Dawidowski, ac Valeria Napolitano,d
Grzegorz Dubin, d Roberto Fino,a Michael S. Ostertag,a Michael Sattler,ae
Grzegorz Popowicz*a and Igor V. Tetko *af
We show that a water envelope network plays a critical role in
protein–protein interactions (PPI). The potency of a PPI inhibitor is
modulated by orders of magnitude on manipulation of the solvent
envelope alone. The structure–activity relationship of PEX14 inhibitors
was analyzed as an example using in silico and X-ray data.
Over the last decade, the analysis of water molecules solvating
protein–ligand binding surfaces was demonstrated to be highly
valuable for drug design.1,2 The most widely employed application
involves high-energy ‘unhappy’ water molecules, which are situated
in deep lipophilic pockets and are often isolated from the rest of
the solvation shell. Their number, arrangement and proximity
were found to be closely connected to the druggability of the
corresponding receptor part.3 Commonly, drug candidates, which
were designed to displace ‘unhappy’ water molecules significantly
benefit from binding enthalpy.4–6 Another case involves energetically
favourable ‘happy’ water molecules. These tightly interact with polar
surface residues and are often involved in a network with other water
molecules in the solvation shell. During a binding event, ‘happy’
water molecules can support protein–ligand complementarity via
mediating their interactions.7,8 Such water-bridges have always been
considered as an important feature in drug design: a ligand-based
project could be complicated due to a poor overlap between ligand
pharmacophore models, while a structure-based project could suffer
because of the lack of reproducibility of X-ray data.9 Despite
numerous studies, the utility of a displacement of ‘happy’ water
molecules is still a matter of discussion.10,11
In case of protein–protein interactions (PPIs), the impact of
water molecules could be even more sophisticated. Due to a
large shallow and solvent-exposed binding surface, PPIs are
often considered as a unique challenge for drug design.12
Recently, Cramer and co-workers reported that inhibition of
PPIs with small molecules could be enhanced by optimization
of the water network wrapping a newly formed complex surface,
‘water envelope’.13 A better adaption of water molecules to an
energetically favourable architecture of the interaction network,
the higher is the potency of the ligand. For example, a E50-fold
increase in affinity was reported for thermolysin inhibitors.14
As a proof-of-concept study, we studied the inhibition of the
PPI involving the T.brucei PEX14 protein and the a-helical motif
of PEX5, which impairs the trypanosome viability.15 We showed
that the direct binding of small-molecule ligands (Fig. 1, right)
to PEX14 is capable of disrupting its interaction with PEX5, and can
efficiently kill trypanosome parasites.15 Structural data indicated an
intricate character of the system where water molecules could have
a critical impact on the interactions. There are no directional
interactions between the ligand and the receptor: binding is driven
by non-polar interactions, while all contacts with polar groups are
water-mediated (Fig. 1, left top). Apart from that, interactions with
‘‘hot spot’’ cavities were not limited by the lipophilicity-driven
structure–activity relationship (SAR) (Fig. 1, left bottom).
To investigate the solvation effects in the PEX14 – inhibitor
complex and check if a water envelope plays a significant role in
the inhibition, we computationally assessed the interaction
surface. The following features were analyzed: (i) geometrical:
radial distribution functions (RDFs, i.e. the probability to find a
water molecule at a particular distance from a solute) and explicit
water positions defined from RDFs and (ii) energetical: free energy
maps (free energy change corresponding to a water transfer from
a particular position around the solute to a bulk solvent).
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All parameters were calculated with a 3D Reference Interacting
Site Model (3D-RISM) implemented in MOE software (Chemical
Computing Group).17 In a number of publications it was shown
that this physically rigorous computational approach reproduced
with high accuracy experimental data on the structure of solvation
shells for various systems.18–20 For PEX14 structures, we revealed an
excellent agreement between the predicted water positions and
high-resolution X-ray data (PDB ID = 5L87; res. = 0.87 Å, see Fig. S8,
ESI†). This observation gave us a solid basis to use the same
approach for the analysis of the ligand-free receptor, where crystal
structures could not be obtained. Details of the 3D-RISM calcula-
tion setup and data analysis are provided in the ESI.† For com-
pounds lacking X-ray structures in the retrospective study as well as
for systems in the prospective study, we performed docking using
the template-docking protocol implemented in MOE software
(details of the protocol setup are provided in the ESI†).
In case of PPIs, it is common that interactions within
‘‘hot-spot’’ (HS) cavities contribute strongest to the binding. There-
fore, modifications of ligand’s groups involved in the interactions
lead to largest changes in the affinity.21 We observed that binding
to cavity HS1 is purely lipophilicity-driven (the chemical composi-
tion of the R1-group is shown in Fig. S9, ESI†). The most
pronounced change in affinity, by one log-unit, is associated with
the growth of the phenyl ring to the naphthyl one: molecular pairs
1–3, and 2–4 (Fig. 1, bottom left, empty crosses). In contrast, the
SAR on the R2-group approaching the HS2 cavity is rather flat with
non-obvious outliers (Fig. 1, bottom left, filled circles).21
We considered two types of R2-groups, based on (i) indole
and (ii) benzyl/naphthyl rings. In both cases, an increase in
lipophilicity does not influence the potency within a series
(whole indole series and compounds 5, 6, and 7 from benzyl/
naphthyl series). However, specific structural changes lead to
iso-lipophilic compounds with quite variable affinity values
(benzyl/naphthyl series: molecular pairs 6–8 and 4–9). The
solvent analysis of the HS2 cavity revealed that water patterns
are different for indole and naphthyl rings (Fig. S10, ESI†).
Upon binding of the indole ring, several water molecules
remained bound to the cavity, whereas the methoxynaphthyl
moiety efficiently displaced all water molecules from the HS2
cavity. This observation agrees with the routine practice of
handing unfavorable water molecules. Notably, the binding of
the methoxynaphthyl fragment was accompanied by a change
in the conformation of the Thr22 residue, which allowed an
optimal shape match between the cavity and R2-group (Fig. S10,
ESI†). It is in line with a lipophilicity-driven change in binding
for molecular pairs 1–2 and 3–4 (Fig. 1, bottom left). For
extreme cases of reduced-potency compounds (8 and 9), we
revealed that very energetically unfavorable water molecules
remained in the cavity after binding (Fig. S10, ESI†).
The solvent analysis in hot-spot cavities is summarized as
follows: (i) binding of inhibitors to the buried and narrow HS1
cavity was purely lipophilicity-driven, while their binding to
shallow HS2 cavity had a more complicated character, (ii) in the
absence of a ligand, the HS2 cavity could accommodate a
network of 3–4 water molecules forming H-bonds with Ser26,
Thr22, and Agr18 residues, and (iii) if any of the water molecules
remained in the cavity after a binding event, their energetic
profile heavily influences the inhibition. The most pronounced
gain in potency was archived by compound 4, which has the
best shape complementarity with the receptor leading to both,
the most efficient non-polar interactions and displacement of
all water molecules from the cavity.
To our surprise, an even more impressive SAR with a compar-
able boost in potency was observed for a water-exposed surface of
the receptor (situated between HS1 and HS2 cavities). We con-
sidered that a solvent analysis of this part of the receptor could
help in better understanding of the water envelope and its role in
inhibition. Here, all contacts between the ligand and receptor are
mediated by 1–2 water molecules (Fig. 1, left top). Solvent analysis
of free and bound states of both the receptor and ligand revealed
that the water molecules belonged mainly to receptor’s solvation
shell. In a complex, they remained tightly coordinated by polar
residues (Fig. 2, middle) and are required for the adaptation of the
ligand to a large flat receptor surface with rather remote polar
regions (Fig. 2, right). Attempts to disrupt the water-bridges
yielded significantly less active inhibitors (Fig. 3). When a water
molecule has the same position in solvation shells of both the
ligand and receptor in their binding conformation, the corres-
ponding water bridge is particularly energetically favorable.
We observed that one water molecule was highly conserved
in all X-ray structures of the inhibitor series (Fig. 2, left).7
It mediated the interactions between the amide-group of
the ligand and peripheral Asn31 residue of the protein. The
particularly conserved position of this water molecule is also
related to the coordination of the backbone and side-chain of
the same residue.
Fig. 1 Right: Selected set of PEX14 inhibitors (see also ref. 16). Left top:
Structure of the complex of the T.brucei PEX14 protein and compound 2
(PDB ID = 5L8A). The protein is represented with a van der Waals surface
colored by yellow – lipophilic, cyan – positively charged, magenta –
negatively charged. The orange surface shows non-polar interactions.
Water molecules near the binding surface are indicated with red spheres.
Left bottom: SAR on R1- and R2-groups of the inhibitors, data points
are shaped with respect to R1-group (empty cross – phenyl group, filled
circle – naphthyl group) and colored by type of R2-group (blue – indole
ring, red – benzyl/naphthyl ring). Dotted lines indicate lipophilicity-driven
binding in cavity HS1, while black dashed arrow showed spread in potency
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According to our model, water molecules mediating protein–
ligand interactions in different parts of the binding surface were
further interconnected between each other by energetically
favourable water molecules forming an extended network –
water envelope (Fig. 4, left, black meshed surface). To evaluate
its impact, we suggest the following structural modifications.
Two spatially separated parts of the network (around Asn13 and
Lys38 residues) could be connected via a carboxylate group
(compound 10). The introduction of the group yielded two
enantiomers, where the (S)-isomer gained in potency and the
(R)-isomer only weakly interacted with PEX14: parent compound
2 pIC50 = 4.2, (S)-isomer pIC50 = 4.8, and (R)-isomer pIC50 =
3.2. Notably, experimental X-ray structures of the (S)-isomer
(PDB ID = 5OML) showed that it formed two additional water-
bridges with the receptor (Fig. 4, middle, WB-2 and WB-3), which
allowed more interconnections within the water envelope.
We also determined the X-ray structure of the weakly inhibiting
(R)-isomer (PDB ID = 6RT2). In this case, we observed that the
carboxylic group has several possible positions including the one
with the direct bond to Lys38 (Fig. 4, right). The direct interaction
of the carboxyl group and primary amine was, however, not
sufficient to compensate for the loss of optimal water network
configuration. These results strongly support the hypothesis of
Cramer and co-workers that the configuration of a water envel-
ope could significantly affect the ligand potency.14
We observed that the presence of water molecules at a
large shallow PEX14 binding surface significantly modulates
inhibitors’ activity leading to a flat unpredictable SAR. Remarkably,
an optimally configured water envelope wrapping/mediating a
primarily lipophilic complex is critical for binding energetics. Not
only water molecules that are bridging the receptor with the ligand
are important but also equally those water molecules that
surround the interface. These molecules have little direct inter-
action with their binding partners, yet their optimal placement
can yield significant improvement in binding. Therefore, studies
on inhibition of PPIs’ interfaces should equally consider: (i) non-
polar interactions within ‘‘hot-spot’’ cavities, (ii) water-bridges
with polar surface residues, and (iii) a water envelope wrapping
the newly formed complex. We suggest here a solvent analysis
protocol based on 3D-RISM calculations as an efficient tool for
the investigation of water envelopes in structure-based drug
design.
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Fig. 2 Water-mediated interactions between PEX14 and ligand 2 (PDB ID =
5L8A). Middle: X-ray water molecules are shown in red, while predicted
water molecules are shown in yellow. Right: Shape complementarity
between the ligand and receptor (color patches represented polar residues),
cyan meshed surfaces indicated predicted water positions). Left: Coordina-
tion of the most energetically stable water bridge (WB-1).
Fig. 3 Matched molecular pairs of ligands, which exhibit high importance
of the water-mediated interactions.
Fig. 4 Water-mediated interactions between inhibitors and polar recep-
tor residues. Crystallographic water molecules are shown in red, while
predicted water molecules are shown in yellow. Left: Complex of PEX14
with ligand 2 (PDB ID = 5L8A). Meshed black surface corresponds to the
radial distribution function g(r) 4 3, green surface reflects the positions of
energetically favorable water molecules (DGdes o 5 kcal mol1). Middle:
Complex of the protein with the S-isomer of ligand 10 (PDB ID = 5OML).
Blue lines show newly formed bonds with respect to parent compound 2
(unaffected water bridges were skipped for simplicity). Right: Complex of
the protein with the R-isomer of ligand 10 (PDB ID = 6RT2). Both possible
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